GET THE APP
Editorial office, Journal of Neurology & Neurophysiology, Brussels, Belgium
Opinion The-Viability And-Risks Of-All-Brutons-Tyrosine-Kinase-Inhibitors-Are-The-Same-No Author(s): Kene Adan* DOI: 10.35248/2471-268X.22.13.10.603
HTML PDF
